NUS · Nu Skin Enterprises, Inc. — research history
Complete research history. Every dossier, draft, kill, publish, and lesson the system has produced on NUS. Public so users can audit, AI can re-reference. Live price refreshes every 60s.
About NUS · Nu Skin Enterprises, Inc.
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands. The company also provides wellness products, such as ageLOC TRME, LifePak, and Beauty Focus. In addition, it is the research and product development of skin care products, nutritional supplements, and devices. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center and independent marketers. It serves Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, comprising Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, consists of Macau; and Europe & Africa, which includes markets in Europe as well as South Africa. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Live Quote
SELL (score -4) · 12-1 mom -23.8% · RSI 33.2 · below_both · -59.8% from high
Targets blend Wall Street consensus (? analysts: low — / mean — / high —) with chart-derived floors and ceilings.
1-Year Chart · RSI · MACD
Research Timeline
Newest first. Each entry shows what stage produced it, the verdict/decision, and the reasoning.
Stage produced output that could not be parsed as a valid JSON object. ~6h cooldown before retry.
{"symbol":"NUS","company":"Nu Skin Enterprises, Inc.","investigation_summary":"NUS has collapsed ~63% from its 52-week high of $14.62 and now trades at just 4x forward earnings with an EV/EBITDA of 2.84 — deeply discounted by any multiple. The four Form-4 filings triggering this investigation are all RSU vestings (code A, price $0), not genuine open-market purchases; the trigger was met because ve